9. Income Taxes
Loss before provision for income taxes was as follows:
|
|
Year Ended December 31,
|
|
|
|
2016
|
|
|
2015
|
|
|
2014
|
|
|
|
(in thousands)
|
|
United States
|
|
$
|
(41,649
|
)
|
|
$
|
(43,626
|
)
|
|
$
|
(36,783
|
)
|
Foreign
|
|
|
(11,752
|
)
|
|
|
(9,235
|
)
|
|
|
(4,587
|
)
|
Total
|
|
$
|
(53,401
|
)
|
|
$
|
(52,861
|
)
|
|
$
|
(41,370
|
)
|
The components of the provision (benefit) for income taxes were as follows:
|
|
Year Ended December 31,
|
|
|
|
2016
|
|
|
2015
|
|
|
2014
|
|
|
|
(in thousands)
|
|
Current:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
State
|
|
|
49
|
|
|
|
16
|
|
|
|
22
|
|
Foreign
|
|
|
183
|
|
|
|
65
|
|
|
|
63
|
|
Total
|
|
|
232
|
|
|
|
81
|
|
|
|
85
|
|
Deferred:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
|
24
|
|
|
|
41
|
|
|
|
—
|
|
State
|
|
|
3
|
|
|
|
5
|
|
|
|
—
|
|
Foreign
|
|
|
(92
|
)
|
|
|
(10
|
)
|
|
|
(28
|
)
|
Total
|
|
|
(65
|
)
|
|
|
36
|
|
|
|
(28
|
)
|
Provision for income taxes
|
|
$
|
167
|
|
|
$
|
117
|
|
|
$
|
57
|
|
F-24
INSTRUCTURE, INC.
Notes to Consolidated Financial Statements
The following reconciles the differences between income taxes computed at the federal statutory rate of 35% and the provision for income taxes :
|
|
Year Ended December 31,
|
|
|
|
2016
|
|
|
2015
|
|
|
2014
|
|
|
|
(in thousands)
|
|
Expected income tax benefit at the federal statutory rate
|
|
$
|
(18,156
|
)
|
|
$
|
(17,972
|
)
|
|
$
|
(14,066
|
)
|
State tax net of federal benefit
|
|
|
(1,767
|
)
|
|
|
(1,703
|
)
|
|
|
(904
|
)
|
Stock-based compensation
|
|
|
1,101
|
|
|
|
2,921
|
|
|
|
2,782
|
|
Stock warrant liability
|
|
|
(21
|
)
|
|
|
222
|
|
|
|
856
|
|
Difference in foreign tax rates
|
|
|
1,553
|
|
|
|
1,090
|
|
|
|
1,524
|
|
Research and development credits
|
|
|
(552
|
)
|
|
|
(397
|
)
|
|
|
(314
|
)
|
Change in valuation allowance
|
|
|
17,798
|
|
|
|
15,615
|
|
|
|
10,114
|
|
Other
|
|
|
211
|
|
|
|
341
|
|
|
|
65
|
|
Income tax provision
|
|
$
|
167
|
|
|
$
|
117
|
|
|
$
|
57
|
|
Deferred Tax Assets and Liabilities
Deferred income taxes reflect the net effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our deferred tax assets and liabilities were as follows:
|
|
Year Ended December 31,
|
|
|
|
2016
|
|
|
2015
|
|
|
2014
|
|
|
|
(in thousands)
|
|
Deferred tax assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net operating loss carryforwards
|
|
$
|
53,693
|
|
|
$
|
37,152
|
|
|
$
|
22,626
|
|
Research and development credits
|
|
|
2,027
|
|
|
|
1,372
|
|
|
|
897
|
|
Accruals and reserves
|
|
|
3,614
|
|
|
|
3,285
|
|
|
|
2,746
|
|
Depreciation
|
|
|
382
|
|
|
|
157
|
|
|
|
286
|
|
Stock-based compensation
|
|
|
2,310
|
|
|
|
1,349
|
|
|
|
611
|
|
Total deferred tax assets
|
|
|
62,026
|
|
|
|
43,315
|
|
|
|
27,166
|
|
Deferred tax liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Intangible assets
|
|
|
(73
|
)
|
|
|
(47
|
)
|
|
|
(20
|
)
|
Capitalized costs
|
|
|
(1,774
|
)
|
|
|
(952
|
)
|
|
|
(409
|
)
|
Total deferred tax liabilities
|
|
|
(1,847
|
)
|
|
|
(999
|
)
|
|
|
(429
|
)
|
Valuation allowance
|
|
|
(60,122
|
)
|
|
|
(42,324
|
)
|
|
|
(26,709
|
)
|
Net deferred tax assets
|
|
$
|
57
|
|
|
$
|
(8
|
)
|
|
$
|
28
|
|
At December 31, 2016, we had $53,693,000 in tax-effected federal, state and foreign net operating loss carryforwards that, if unused, begin expiring in 2018. Additionally, we had $3,040,000 of tax-effected carryforwards related to excess tax benefits for stock-based compensation. These operating loss carryforwards, if unused, begin expiring in 2018. Finally, at December 31, 2016, we had $3,395,000 in income tax credits, consisting primarily of federal and state research and development tax credits. These tax credits, if unused, begin expiring in 2023.
We review all available evidence to evaluate our recovery of deferred tax assets, including our recent history of accumulated losses in all tax jurisdictions over the most recent three years as well as our ability to generate income in future periods. We have provided a valuation allowance against our U.S. net deferred tax assets as it is more likely than not that these assets will not be realized given the nature of the assets and the likelihood of future utilization.
The valuation allowance increased by $17,798,000 and $15,615,000 in 2016 and 2015, respectively, due to the increase in the deferred tax assets primarily due to the increase in the net operating loss carryforwards.
F-25
Dostları ilə paylaş: |